<--- Back to Details
First PageDocument Content
Pharmaceutical sciences / Antidotes / Chelating agents / Phenols / Design of experiments / Deferasirox / Clinical trial / Deferoxamine / Beta-thalassemia / Chemistry / Pharmacology / Medicine
Date: 2005-09-28 09:35:02
Pharmaceutical sciences
Antidotes
Chelating agents
Phenols
Design of experiments
Deferasirox
Clinical trial
Deferoxamine
Beta-thalassemia
Chemistry
Pharmacology
Medicine

Microsoft Word - MOR-redacted-CDER-AC-BGP[removed]doc

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 2,48 MB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xvUb - View Document

PDF Document

DocID: 1xc8R - View Document

Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME

DocID: 1vqsj - View Document

Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia

DocID: 1vlJU - View Document

Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology

DocID: 1vk1K - View Document